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Abstract
Background: Littoral cell angioma (LCA) is a rare vascular tumor of the spleen. Generally thought to be benign,
additional cases of LCA with malignant features have been described. Thus, its malignant potential seems to vary
and must be considered uncertain. The etiology remains unclear, but an immune dysregulation for the apparent
association with malignancies of visceral organs or immune-mediated diseases has been proposed.
Case Presentation: We report a case of LCA in a 43-year old male patient who presented with a loss of appetite
and intermittent upper abdominal pain. Computed tomography showed multiple hypoattenuating splenic lesions
which were hyperechogenic on abdominal ultrasound. Lymphoma was presumed and splenectomy was
performed. Pathological evaluation revealed LCA.
Conclusions: LCA is a rare, primary vascular neoplasm of the spleen that might etiologically be associated with
immune dysregulation. In addition, it shows a striking association with synchronous or prior malignancies. With
about one-third of the reported cases to date being co-existent with malignancies of visceral organs or immune-
mediated diseases, this advocates for close follow-ups in all patients diagnosed with LCA. To our knowledge, this
report is the first one of LCA associated with previous pulmonary sarcoidosis and hypothesizes a TNF-a related
pathogenesis of this splenic tumor.
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Background
Vascular tumors are the most common primary neo-
plasms of the spleen. Among these, LCA is a very rare
tumor which arises from the littoral cells lining the sinuses
o ft h es p l e n i cr e dp u l p .T h et u m o rd i s p l a y sau n i q u e
immunohistochemical phenotype of dual endothelial and
histiocytic differentiation but is difficult to differentiate
from other benign and malignant splenic lesions preopera-
tively. Thus, diagnosis is usually established after elective
splenectomy. Currently, both etiology as well as biological
behavior remain uncertain. Increasing numbers of LCA in
association with autoimmune disorders or visceral organ
tumors have been reported which hypothesizes an immu-
nological association of this entity.
Case presentation
A 43-year old male presented with non-specific clinical
symptoms such as loss of appetite and intermittent upper
abdominal pain which improved slightly with antacid
medication. His medical history was unremarkable except
for pulmonal sarcoidosis in his twenties which had been
treated with corticosteroid medication. Both physical
examination and laboratory tests were without pathologi-
cal findings. An ulcerous lesion in the duodenum was
detected gastroscopically and computed tomography was
performed to exclude an external compressing tumor. CT
scans (Figure 1) did not detect any tumor but revealed
mild splenomegaly with multiple hypoattenuating nodules
with a maximum diameter of 2.5 cm which were contrast-
enhancing in the late portal venous phase.
Abdominal ultrasound revealed multiple hyperecho-
genic splenic lesions without evidence of metastatic dis-
ease or infectious origin and hemangioma was assumed.
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considered the most likely diagnosis, given the quantity
of the nodules as well as their distribution within the
spleen and splenectomy was advocated. After appropriate
preoperative vaccination for Streptococcus pneumoniae,
Haemophilus influenca B and Neisseria meningitidis,
laparoscopic splenectomy was performed. The cut sur-
f a c eo ft h e1 2×8×4c ms p e c i m e n( F i g u r e2 )s h o w e d
multiple nodular lesions with spongy appearance, varying
from 0.5 to 2 cm in greatest dimension.
Microscopically, these lesions were composed of
cavernous sinuses which were lined by a single layer of
tall cells (Figure 3) lacking typical endothelial features.
The lacunae were filled with edematous fluid and blood
(Figure 4). Immunohistochemical staining (Figure 5) was
positive for both endothelial (CD 31) and histiocytic
(CD 68) markers. No cytologic atypia and mitotic figures
were found.
The combination of morphological and immunohisto-
chemical analysis presenting this hybrid endothelial-his-
tiocytic phenotype established the diagnosis of LCA.
The postoperative course was uneventful and the patient
was discharged on day five. He will be followed-up clo-
sely for the occurrence t of visceral neoplasms.
Discussion
Littoral cell angioma (LCA) is a rare vascular tumor that
occurs exclusively in splenic tissue and was first
described by Falk et al in 1991 [1]. It originates from the
specialized endothelial cells lining the sinus channels of
the splenic red pulp, called “littoral cells”.L C As h o w
neither gender nor age predilection. It might be discov-
ered incidentally in completely asymptomatic patients or
in those presenting with non-specific clinical symptoms
like in our case. About 50% of all patients show spleno-
megaly or signs of hypersplenism like anemia or throm-
bocytopenia [1]. On ultrasound, the findings vary widely
from heterogeneous echotexture without specific nodules
[2] to hyperechogenic [3], hypoechogenic [4] or isoecho-
genic [5] appearing lesions [6-8]. Computed tomography
typically shows multiple hypoattenuating nodules [9].
These findings are non-specific and several differential
diagnosis have to be considered. These include benign
neoplasms like hamartoma or hemangioma but also
metastatic diseases or disseminated infections [2]. Since
Figure 1 Computed tomography showing multiple
hypoattenuating lesions (arrows).
Figure 2 Splenectomy-specimen revealing multiple nodular
lesions with spongy appearance (arrows).
 
Figure 3 Neoplastic sinuses lined by a single cell layer (20×
obj, HE-staining).
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other organs, metastatic disease was considered an unli-
kely diagnosis. Considering disseminated infections, we
had to exclude fungal disease, septic emboli and granulo-
matous diseases such as sarcoidosis and tuberculosis.
Associated adenopathic, pulmonary and mediastinal dis-
eases suspecting sarcoidosis or tuberculosis were not
detected. Mycobacterium avium-intracellulare complex,
Pneumocystic carinii and disseminated Kaposi sarcoma
may also cause splenic masses but are typically seen in
immunocompromised individuals. After elaborating for
these differentials, a definite diagnosis is often still diffi-
cult to obtain and splenectomy is subsequently per-
formed for further evaluation. Gross pathology typically
shows multiple focal blood-filled nodules and micro-
scopic examination reveals anastomosing vascular
channels lined with tall endothelial cells and papillary
fronds [1,7,9].
Since the littoral cells have features intermediate
between those of endothelial cells and macrophages,
they show a hybrid endothelial-histiocytic phenotype on
immunohistochemical staining. Expression of endothelial
marker factor VIII-related antigen and also of histiocytic
markers such as CD68 and lysozyme is thought to be
characteristic for LCA [1,6,7] and establishes the final
diagnosis.
Generally thought to be benign, there are additional
reports of LCA with malignant features which were
divided into a low-grade variant (littoral cell heman-
gioendothelioma [10]) and the tumor’s malignant coun-
terpart, littoral cell angiosarcoma [11]. Therefore, its
biological behavior seems to vary and must be consid-
ered uncertain [9].
The etiology of this neoplasm also remains unclear, but
for its apparent association with visceral organ tumors
and immune-mediated diseases in one-third of the
reported cases to date [12-16], an etiological association
with immune dysregulation has been proposed [1,17,18].
To support this contention, there are more reports of
LCA in patients with long-term immunosupressive ther-
apy, i.e. after renal transplantation [18] or for systemic
lupus erythematosus [19]. Reviewing literature for simila-
rities of immune-mediated diseases and LCA we found
two cases of LCA in patients with Gaucher’s disease
[20,21], a lipid storage disorder characterized by accumu-
lation of cerebroside in the cytoplasm of macrophages
due to deficiency of an enzyme, glucocerebrosidase
[20,21]. Both LCA and Gaucher’s disease involve lyso-
zymes. Since the likelihood of chance occurrence of two
rare disorders in one patient is low, Gupka et al sug-
gested a possible pathophysiologic association [20].
Since our patient had a history of pulmonal sarcoido-
sis, we concentrated on possible immunological links
between these two entities.
In sarcoidosis, a multisystemic granulomatous disorder
of unknown origin, the inflammatory response is charac-
terized by the increased production of several pro-
inflammatory cytokines which mainly belong to the
tumor necrosis factor family. Tumor necrosis factor-
alpha (TNF-a) is considered the pivotal factor in the
formation of granulomas by mediating inflammation
and cellular immune response among the cytokines
involved [22]. TNF-a is released by macrophages and
binds to two types of receptors, the 55 kDa (TNF recep-
tor I: TNF RI) and the 75 kDa receptor (TNF RII) [23].
Elevated serum levels of these receptors have been
demonstrated in a variety of diseases, e.g. rheumatic dis-
eases, malignancies and Crohn’s disease, and are thought
to reflect the disease activity. Since LCA is a neoplasm
arising from the lining cells, the spleen’s macrophages,
 
Figure 4 Regular splenic parenchyma (right) and tumor (left)
composed of lacunae filled with oedematous fluid and blood
(4× obj, HE-staining).
Figure 5 Combined expression of endothelial (CD31) and
histiocytic (CD68) markers in immunohistochemical staining.
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TNF-a, eventually contributing to the pathogenesis of
LCA, since inflammatory cells including TNF-a are
known to have powerful effects on tumor development,
producing an attractive environment for tumor growth
by facilitating genomic instability and promoting angio-
genesis. The inflammatory cells as well as the chemo-
kines and cytokines they produce finally influence the
whole tumor organ, regulating the growth, migration
and differentiation of all cell types in the tumor micro-
environment, including neoplastic cells, fibroblasts and
endothelial cells [24]. Thus, a TNF-a related pathogen-
esis of LCA could also provide an explanation for both
the occurrence of synchronous or metachronous visceral
o r g a nt u m o r sa sw e l la st h ea f f e c t i o nf o ri m m u n e -
mediated diseases.
Conclusions
LCA is a rare, primary vascular neoplasm of the spleen.
Currently, both etiology and biological behavior remain
unclear, but an underlying immune dysregulation has
been proposed for LCA’s association with malignancies
of visceral organs or immune-mediated disorders in
about one-third of the reported cases. Our case presenta-
tion supports the assumption of an association of LCA
and an altered immune status, hypothesizing a TNF-a-
related pathogenesis of this splenic tumor. Close follow-
u p so fp a t i e n t sd i a g n o s e dw i t hL C Af o rs u b s e q u e n t
development of additional tumors is mandatory.
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